11Mar 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, the postoperative administration of radioiodine (iodine-131) is controversial without demonstrated benefits. In patients with low-risk thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve radioiodine was non-inferior to an ablation strategy with radioiodine regarding the occurrence of functional, structural, and biologic events at three years.

  • #family health

Like

Save

Share